Acamprosate Calcium bulk completed European COS approval.

Published: 2002-04-01 06:59:00

Updated: 2002-04-01 06:59:00

Estech Pharma., a local venture company, successfully gained the European COS approval for Acamprosate Calcium bulk, an alcohol detoxicate agent, on March 8, which was the 3rd event in it's overseas registration.

COS (Certification of Suitability of Monographs of the European Pharmacopoeia) is...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK